Results 181 to 189 of about 3,096 (189)
Some of the next articles are maybe not open access.

Retreatment with brentuximab vedotin in patients with CD30-positive hematologic malignancies

Journal of Hematology and Oncology, 2014
Nancy L Bartlett   +2 more
exaly  

Disitamab vedotin/enfortumab vedotin/pembrolizumab

Reactions Weekly
openaire   +1 more source

Enfortumab-vedotin/Insulin

Reactions Weekly
openaire   +1 more source

Brentuximab vedotin — a new standard for cutaneous T-cell lymphoma

Nature Reviews Clinical Oncology, 2017
exaly  

Pembrolizumab/Enfortumab vedotin

Reactions Weekly
openaire   +1 more source

Enfortumab-vedotin/nivolumab

Reactions Weekly
openaire   +1 more source

Tisotumab vedotin effective in recurrent cervical cancer

Nature Reviews Clinical Oncology
exaly  

Adding brentuximab vedotin to lenalidomide and rituximab improves OS in R/R DLBCL

Nature Reviews Clinical Oncology
exaly  

Clobetasol/enfortumab-vedotin

Reactions Weekly
openaire   +1 more source
urothelial carcinoma
urothelial cancer
bladder cancer
metastatic urothelial carcinoma
pembrolizumab
antibody-drug conjugate
nectin-4
antibody–drug conjugates
efficacy
previous   17  18  19  

Home - About - Disclaimer - Privacy